Using the Score Test to Identify the Longitudinal Biomarker Considering Accelerate Failure Time Model with the Frailty in Survival Analysis

Quality of life (QOL) is looked upon as a multidimensional entity comprising physical, psychological, social, and medical parameters. QOL is a good prognostic factor for the cancer patients. In this article, we want to determine if QOL is a good biomarker as a surrogate to indicate the survival time of gastric cancer patients. We conducted a single institutional trial and examines QOL of gastric cancer patients receiving the different surgery. In this trial, QOL is a longitudinal measurement. The accelerated failure time model can be used to deal with survival data when the proportionality assumption fails to capture the relationship between the survival time and covariates. In this article, similar to Henderson et al. (2000 Henderson , R. , Diggle , P. , Dobson , A. ( 2000 ). Joint modelling of longitudinal measurements and event time data . Biostatistics 1 ( 4 ): 465 – 480 .[Crossref], [PubMed] , [Google Scholar], 2002 Henderson , R. , Diggle , P. J. , Dobson , A. ( 2002 ). Identification and efficacy of longitudinal markers for survival . Biostatistics 3 ( 1 ): 33 – 50 .[Crossref], [PubMed], [Web of Science ®] , [Google Scholar]), a joint likelihood function combines the likelihood functions of the longitudinal biomarkers and the survival times under the accelerated failure time assumption. We introduce a method employing a frailty model to identify longitudinal biomarkers or surrogates for a time to event outcome. We allow random effects to be present in both the longitudinal biomarker and underlying survival function. The random effects in the biomarker are introduced via an explicit term while the random effect in the underlying survival function is introduced by the inclusion of frailty into the model. We will introduce a method to identify longitudinal biomarkers or surrogates for a time to event outcome based on the accelerated failure time assumption.